Link: Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance
Link: Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance
See the original post here: Cellectis’ Shareholders Meeting to be Held on December 22, 2023
View original post here: Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers
See the article here: GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023
Follow this link: Polaris Group Initiates Rolling Submission of Biologic License Application (BLA) for ADI-PEG 20 with U.S. FDA to Treat Malignant Pleural Mesothelioma
Visit link: First Product Incorporating Arecor’s Arestat Technology, At220, Launched in Europe
Read more here: Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award
Go here to see the original: Mendus Announces Nomination Committee for the 2024 Annual General Meeting
Read this article: Medicenna Announces Compelling Survival Benefit from Phase 2b Study of Bizaxofusp in Recurrent Glioblastoma at the 28th Annual Meeting of the Society...
Continue reading here: Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
Recent Comments